Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cartesian Therapeutics (RNAC) Gains from Investment Securities (2016 - 2026)

Cartesian Therapeutics (RNAC) has disclosed Gains from Investment Securities for 12 consecutive years, with -$94000.0 as the latest value for Q1 2026.

  • For Q1 2026, Gains from Investment Securities rose 94.83% year-over-year to -$94000.0; the TTM value through Mar 2026 reached -$5.0 million, down 539.05%, while the annual FY2025 figure was -$3.7 million, N/A changed from the prior year.
  • Gains from Investment Securities hit -$94000.0 in Q1 2026 for Cartesian Therapeutics, up from -$3.7 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $6.5 million in Q3 2022 and bottomed at -$21.0 million in Q4 2022.
  • Average Gains from Investment Securities over 5 years is -$2.5 million, with a median of -$654000.0 recorded in 2025.
  • On a YoY basis, Gains from Investment Securities climbed as much as 1204.56% in 2022 and fell as far as 999.06% in 2022.
  • Cartesian Therapeutics' Gains from Investment Securities stood at -$21.0 million in 2022, then skyrocketed by 97.73% to -$477000.0 in 2023, then skyrocketed by 687.63% to $2.8 million in 2024, then plummeted by 231.82% to -$3.7 million in 2025, then skyrocketed by 97.46% to -$94000.0 in 2026.
  • According to Business Quant data, Gains from Investment Securities over the past three periods came in at -$94000.0, -$3.7 million, and -$516000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.